Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein.

Marker DF, Puccini JM, Mockus TE, Barbieri J, Lu SM, Gelbard HA.

J Neuroinflammation. 2012 Nov 29;9:261. doi: 10.1186/1742-2094-9-261.

2.

The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

Schapansky J, Nardozzi JD, LaVoie MJ.

Neuroscience. 2015 Aug 27;302:74-88. doi: 10.1016/j.neuroscience.2014.09.049. Epub 2014 Oct 2. Review.

3.

Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions.

Minghetti L, Visentin S, Patrizio M, Franchini L, Ajmone-Cat MA, Levi G.

Neurochem Res. 2004 May;29(5):965-78. Review.

PMID:
15139295
4.

Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: implications for HIV-associated neurocognitive disorders.

Giunta B, Ehrhart J, Obregon DF, Lam L, Le L, Jin J, Fernandez F, Tan J, Shytle RD.

Mol Brain. 2011 Jun 7;4(1):23. doi: 10.1186/1756-6606-4-23. Review.

5.

Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E.

Curr HIV Res. 2015;13(1):43-54. Review.

6.

Fate of microglia during HIV-1 infection: From activation to senescence?

Chen NC, Partridge AT, Sell C, Torres C, Martín-García J.

Glia. 2017 Mar;65(3):431-446. doi: 10.1002/glia.23081. Epub 2016 Nov 26. Review.

PMID:
27888531
7.

Phosphatidylinositol (4,5)-bisphosphate-mediated pathophysiological effect of HIV-1 Tat protein.

Beaumelle B, Tóth P, Malak OA, Chopard C, Loussouarn G, Vitale N.

Biochimie. 2017 Oct;141:80-85. doi: 10.1016/j.biochi.2017.05.014. Epub 2017 May 23. Review.

PMID:
28549840
8.

Impact of opiate-HIV-1 interactions on neurotoxic signaling.

Hauser KF, El-Hage N, Buch S, Nath A, Tyor WR, Bruce-Keller AJ, Knapp PE.

J Neuroimmune Pharmacol. 2006 Mar;1(1):98-105. Review.

PMID:
18040795
9.
10.

The impact of HIV-1 on neurogenesis: implications for HAND.

Ferrell D, Giunta B.

Cell Mol Life Sci. 2014 Nov;71(22):4387-92. doi: 10.1007/s00018-014-1702-4. Epub 2014 Aug 19. Review.

11.

Modulators of microglial activation and polarization after intracerebral haemorrhage.

Lan X, Han X, Li Q, Yang QW, Wang J.

Nat Rev Neurol. 2017 Jul;13(7):420-433. doi: 10.1038/nrneurol.2017.69. Epub 2017 May 19. Review.

12.

Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease.

Vilalta A, Brown GC.

FEBS J. 2017 Nov 10. doi: 10.1111/febs.14323. [Epub ahead of print] Review.

PMID:
29125686
13.

HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models of HIV-associated neurocognitive disorder.

Ye X, Zhang Y, Xu Q, Zheng H, Wu X, Qiu J, Zhang Z, Wang W, Shao Y, Xing HQ.

Oncotarget. 2017 Jun 13;8(24):39922-39934. doi: 10.18632/oncotarget.16485. Review.

14.

Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.

Morara S, Colangelo AM, Provini L.

Neural Plast. 2015;2015:135342. doi: 10.1155/2015/135342. Epub 2015 Jul 26. Review.

15.

Human Immunodeficiency Virus Promotes Mitochondrial Toxicity.

Rozzi SJ, Avdoshina V, Fields JA, Trejo M, Ton HT, Ahern GP, Mocchetti I.

Neurotox Res. 2017 Nov;32(4):723-733. doi: 10.1007/s12640-017-9776-z. Epub 2017 Jul 10. Review.

PMID:
28695547
16.

Monitoring in vivo function of cortical microglia.

Brawek B, Garaschuk O.

Cell Calcium. 2017 Jun;64:109-117. doi: 10.1016/j.ceca.2017.02.011. Epub 2017 Mar 14. Review.

PMID:
28359543
17.

Autophagy in the pathogenesis of ankylosing spondylitis.

Ciccia F, Haroon N.

Clin Rheumatol. 2016 Jun;35(6):1433-6. doi: 10.1007/s10067-016-3262-5. Epub 2016 Apr 13. Review.

PMID:
27075464
18.

Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology.

Pena-Ortega F.

Curr Neuropharmacol. 2017;15(4):595-619. doi: 10.2174/1570159X14666160928151546. Review.

19.

Microglial Phenotypes and Functions in Multiple Sclerosis.

O'Loughlin E, Madore C, Lassmann H, Butovsky O.

Cold Spring Harb Perspect Med. 2018 Feb 1;8(2). pii: a028993. doi: 10.1101/cshperspect.a028993. Review.

PMID:
29419406
20.

Microglia: An Interface between the Loss of Neuroplasticity and Depression.

Singhal G, Baune BT.

Front Cell Neurosci. 2017 Sep 8;11:270. doi: 10.3389/fncel.2017.00270. eCollection 2017. Review.

Supplemental Content

Support Center